Compare · CHRA vs LH
CHRA vs LH
Side-by-side comparison of Charah Solutions Inc. (CHRA) and Labcorp Holdings Inc. (LH): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHRA operates in Utilities, while LH operates in Health Care - the two are in different parts of the market.
- LH carries a market cap of $30.24B.
- LH has hit the wire 11 times in the past 4 weeks while CHRA has been quiet.
- LH has more recent analyst coverage (25 ratings vs 1 for CHRA).
- Company
- Charah Solutions Inc.
- Labcorp Holdings Inc.
- Price
- -
- -
- Market cap
- -
- $30.24B
- 1M return
- -
- +16.48%
- 1Y return
- -
- +42.25%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 0
- 11
- Recent ratings
- 1
- 25
Charah Solutions Inc.
Charah Solutions, Inc. provides environmental services to the power generation industry in the United States. The company offers remediation and compliance services, including environmental management of landfills for coal-fired power generation facilities and new and existing ash ponds; active pond management services, such as closure by removal, cap-in-place, and design and construction of new ponds. Its remediation and compliance services also include landfill development, construction, and management; site evaluation and characterization; preliminary design and cost estimates with life-cycle analysis; hydrogeological assessment; groundwater and containment modeling; permit application and processing for expansions and greenfield sites; design engineering; construction of landfills and cap and cover systems; conversion of impoundments to landfill sites; quality assurance and control, and documentation; engineered fills (off-site); and other related services. In addition, the company recycles recurring and contracted volumes of coal-fired power generation waste byproducts comprising bottom ash, fly ash, and gypsum byproducts for the use in various industrial purposes. Further, it provides coal ash management services; fossil services that include silo management, on-site ash transportation, and capture and disposal of ash byproduct from coal power operations; and manages combustion byproducts comprising bottom ash, as well as disposal of flue gas desulfurization gypsum, Pozatec/fixated scrubber sludge, and fluidized bed combustion fly ash; and environmental risk transfer services that manages the sites' remediation requirements. Charah Solutions, Inc. was founded in 1987 and is headquartered in Louisville, Kentucky.
Labcorp Holdings Inc.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty Testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. In addition, it provides online and mobile applications to enable patients to check test results; patient self-service apps; and online applications for managed care organizations. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Latest CHRA
- Charah Solutions Names Tony Tomljanovic as Chief Financial Officer and Treasurer
- SEC Form 15-12G filed by Charah Solutions Inc.
- Charah Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form EFFECT filed by Charah Solutions Inc.
- SEC Form SC 13D/A filed by Charah Solutions Inc. (Amendment)
- SEC Form 4 filed by Bcp Energy Services Fund Ugp, Llc
- SEC Form 4 filed by Blossman Jack A Jr
- SEC Form 4 filed by Skidmore Joseph
- SEC Form 4 filed by Whalen Dennis Thomas
- SEC Form 4 filed by Simon Timothy Alan
Latest LH
- EVP, Pres of BLS, CMO & CSO Caveney Brian J sold $744,080 worth of shares (2,000 units at $372.04), decreasing direct ownership by 5% to 34,562 units (SEC Form 4)
- EVP and President, Diagnostics Vaughn Bryan T sold $108,232 worth of shares (306 units at $353.70) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 6,845 units (SEC Form 4)
- Labcorp Holdings Inc. upgraded by HSBC Securities with a new price target
- Labcorp Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Labcorp to Speak at the UBS Global Healthcare Conference
- Director Parham Richelle P sold $389,395 worth of shares (1,078 units at $361.22), decreasing direct ownership by 32% to 2,288 units (SEC Form 4)
- EVP, CIO & CTO Oyegunwa Akinbolade converted options into 370 shares and covered exercise/tax liability with 118 shares, increasing direct ownership by 5% to 5,316 units (SEC Form 4) to satisfy tax liability
- EVP and President, Diagnostics Vaughn Bryan T converted options into 500 shares and covered exercise/tax liability with 194 shares, increasing direct ownership by 4% to 7,151 units (SEC Form 4) to cover taxes
- SEC Form 10-Q filed by Labcorp Holdings Inc.
- SEC Form 8-K filed by Labcorp Holdings Inc.